BIBI N, MALIK M. COMPARISON OF 550MG/DAY VERSES 1100 MG/DAY RIFAXIMIN IN SECONDARY PREVENTION OF BOTH COVERT AND OVERT HEPATIC ENCEPHALOPATHY. Pak J Intens Care Med [Internet]. 2025May15 [cited 2025May31];5(01):71. Available from: https://pjicm.com/ojs/index.php/home/article/view/71